In 1933, Dr. Kinji Miyairi from Chiba Medical University (now Chiba University School of Medicine) discovered the Miyairi bacteria (Miyairi strain of butyric acid bacteria). Since its establishment, Miyarisan Pharmaceutical has continuously explored the potential of the Miyairi bacteria and has been dedicated to the health of humans and animals around the world.
Generic Name: Clostridium Butyricum Powders
Registered Trademark: 米雅®
Appearance: A white or grayish white uniform fine particle with a slight odor of butyricum.
Strength: The viable count of Clostridium butyricum should be 1.0×10^6~1.0×10^9CFU/g
Approval number: 国药准字SJ20140075; 国药准字SJ20140076
Marketing Authorization Holder: Miyarisan Pharmaceutical Co., Ltd
Manufacturer:Miyarisan Pharmaceutical Co., Ltd
Indication:Treat and improve digestive symptoms caused by gut microbiota disorders due to various reasons.
Generic Name: Clostridium Butyricum Tablets
Registered Trademark: 米雅®
Appearance: A white or grayish white tablets with a slight odor of butyricum.
Strength: The viable count of Clostridium butyricum should be 3.5×10^5~3.5×10^8 CFU/tablet
Approval number: 国药准字SJ20140080
Marketing Authorization Holder: Miyarisan Pharmaceutical Co., Ltd
Manufacturer:Miyarisan Pharmaceutical Co., Ltd
Indication:Treat and improve digestive symptoms caused by gut microbiota disorders due to various reasons.
